Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02077114
What this trial is testing

Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma

Who this might be right for
Malignant Melanoma With Metastasis
Herlev Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02816021
What this trial is testing

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02223884
What this trial is testing

Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Who this might be right for
Malignant Melanoma
Yonsei University 30
Testing effectiveness (Phase 2)Ended earlyNCT00849875
What this trial is testing

Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Study completedNCT00232726
What this trial is testing

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Who this might be right for
Malignant MelanomaNeoplasm Metastasis
Clavis Pharma 42
Testing effectiveness (Phase 2)UnknownNCT03166397
What this trial is testing

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma Stage IV
Sheba Medical Center 30
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Large-scale testing (Phase 3)Study completedNCT01307397
What this trial is testing

Vemurafenib in Participants With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 3,219
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Testing effectiveness (Phase 2)Study completedNCT01884961
What this trial is testing

Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Who this might be right for
Metastatic Renal Cell CancerMalignant Melanoma, Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 46
Large-scale testing (Phase 3)Study completedNCT00055562
What this trial is testing

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
Celgene Corporation 274
Testing effectiveness (Phase 2)Study completedNCT00533702
What this trial is testing

IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Eli Lilly and Company 106
Testing effectiveness (Phase 2)UnknownNCT05087602
What this trial is testing

Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma

Who this might be right for
Locally Advanced or Metastatic Acral Malignant Melanoma
Qilu Hospital of Shandong University 29
Testing effectiveness (Phase 2)Ended earlyNCT00304200
What this trial is testing

Temodar and Sutent as Therapy for Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Northern California Melanoma Center 7
Testing effectiveness (Phase 2)UnknownNCT02452294
What this trial is testing

Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)

Who this might be right for
Malignant MelanomaMetastases
University Hospital Tuebingen 22
Testing effectiveness (Phase 2)Looking for participantsNCT06209580
What this trial is testing

AMT-253 in Patients With Advanced Solid Tumours

Who this might be right for
Malignant MelanomaAdvanced Solid Tumors
Multitude Therapeutics Inc. 96
Testing effectiveness (Phase 2)Ended earlyNCT00068666
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 41
Testing effectiveness (Phase 2)UnknownNCT05094804
What this trial is testing

OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+7 more
OncoResponse, Inc. 172
Large-scale testing (Phase 3)Study completedNCT00057616
What this trial is testing

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

Who this might be right for
MelanomaNeoplasm Metastasis
Celgene 274
Early research (Phase 1)Study completedNCT01239134
What this trial is testing

Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors

Who this might be right for
Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies
Leap Therapeutics, Inc. 10
Next Page